PMC:7283670 / 35507-35762 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T67712","span":{"begin":45,"end":49},"obj":"Body_part"}],"attributes":[{"id":"A93849","pred":"fma_id","subj":"T67712","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":"Spectrum of disease: mean number of involved lung segments: 10.5 (SD 6.4): group 1: subclinical patients (CT before symptom onset): 2.8 (3.3), group 2: ≤1 week after symptom onset/11.1 (5.4), group 3: \u003e1–2 weeks/13.0 (5.7), group 4: \u003e2–3 weeks/12.1 (5.9)."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T64","span":{"begin":45,"end":49},"obj":"Body_part"}],"attributes":[{"id":"A64","pred":"uberon_id","subj":"T64","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"Spectrum of disease: mean number of involved lung segments: 10.5 (SD 6.4): group 1: subclinical patients (CT before symptom onset): 2.8 (3.3), group 2: ≤1 week after symptom onset/11.1 (5.4), group 3: \u003e1–2 weeks/13.0 (5.7), group 4: \u003e2–3 weeks/12.1 (5.9)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T333","span":{"begin":45,"end":49},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T334","span":{"begin":45,"end":49},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"}],"text":"Spectrum of disease: mean number of involved lung segments: 10.5 (SD 6.4): group 1: subclinical patients (CT before symptom onset): 2.8 (3.3), group 2: ≤1 week after symptom onset/11.1 (5.4), group 3: \u003e1–2 weeks/13.0 (5.7), group 4: \u003e2–3 weeks/12.1 (5.9)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T75","span":{"begin":66,"end":68},"obj":"Chemical"},{"id":"T76","span":{"begin":75,"end":80},"obj":"Chemical"},{"id":"T77","span":{"begin":143,"end":148},"obj":"Chemical"},{"id":"T78","span":{"begin":192,"end":197},"obj":"Chemical"},{"id":"T79","span":{"begin":224,"end":229},"obj":"Chemical"}],"attributes":[{"id":"A75","pred":"chebi_id","subj":"T75","obj":"http://purl.obolibrary.org/obo/CHEBI_74807"},{"id":"A76","pred":"chebi_id","subj":"T76","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A77","pred":"chebi_id","subj":"T77","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A78","pred":"chebi_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A79","pred":"chebi_id","subj":"T79","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"Spectrum of disease: mean number of involved lung segments: 10.5 (SD 6.4): group 1: subclinical patients (CT before symptom onset): 2.8 (3.3), group 2: ≤1 week after symptom onset/11.1 (5.4), group 3: \u003e1–2 weeks/13.0 (5.7), group 4: \u003e2–3 weeks/12.1 (5.9)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T303","span":{"begin":60,"end":131},"obj":"Sentence"},{"id":"T304","span":{"begin":132,"end":255},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Spectrum of disease: mean number of involved lung segments: 10.5 (SD 6.4): group 1: subclinical patients (CT before symptom onset): 2.8 (3.3), group 2: ≤1 week after symptom onset/11.1 (5.4), group 3: \u003e1–2 weeks/13.0 (5.7), group 4: \u003e2–3 weeks/12.1 (5.9)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1120","span":{"begin":96,"end":104},"obj":"Species"}],"attributes":[{"id":"A1120","pred":"tao:has_database_id","subj":"1120","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Spectrum of disease: mean number of involved lung segments: 10.5 (SD 6.4): group 1: subclinical patients (CT before symptom onset): 2.8 (3.3), group 2: ≤1 week after symptom onset/11.1 (5.4), group 3: \u003e1–2 weeks/13.0 (5.7), group 4: \u003e2–3 weeks/12.1 (5.9)."}